Article citationsMore>>

Hickman, I.J., Powell, E.E., Prins, J.B., et al. (2003) In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: Implications for therapy. Journal of Hepatology, 39, 1042-1048. doi:10.1016/S0168-8278(03)00463-X

has been cited by the following article:

• TITLE: The effect of age, gender, level of adiposity and diabetes duration on glycated hemoglobin reduction after anti-diabetic therapy in type-2 diabetic patients

  AUTHORS: Chinwe O. Ewenighi, Uchechukwu Dimkpa, Babatunde I. Adejumo, Joel C. Onyeanusi, Isaac N. Nnatuanya, Uzor Simon, Linus U. M. Onoh, Uchechukwu Ezeugwu

  KEYWORDS: Glycated Hemoglobin; Age; Gender; Adiposity; Metformin; Diet

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.2 No.2, May 25, 2012

  ABSTRACT: Background: It is established that glycemic control measures involving diet and oral medication reduce glycated hemoglobin concentration (HbA1c) in type-2 diabetic patients. Aim: We aimed to determine whether HbA1c reduction after diabetic treatment is affected by age, gender, level of adiposity and diabetes duration in type-2 diabetic patients. Methods: One hundred and four type-2 diabetic patients participated in a 20-week diabetic control therapy involving oral medication (metformin) and lifestyle intervention (diet). We compared the HbA1c reduction after treatment between the elderly and non-elderly; males and females; overweight/obese and non-overweight/obese; and long-standing and newly diagnosed patients. Results: After the treatment, participants had mean HbA1c reduction of 1.1 ± 1.31% and weight loss of 2.46 ± 1.79 kg. Forty-six (44.2%) of the patients had acceptable HbA1c level of p p p